Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes

JP Courreges; Tina Vilsbøll; M Zdravkovic; T Le-Thi; T Krarup; O Schmitz; R Verhoeven; I Buganova; Sten Madsbad

Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes

JP Courreges, Tina Vilsbøll, M Zdravkovic, T Le-Thi, T Krarup, O Schmitz, R Verhoeven, I Buganova, Sten Madsbad

Department of Clinical Medicine

Original language	English
Journal	Diabetic Medicine
Volume	28
Issue number	9
Pages (from-to)	1129-1131
ISSN	0742-3071
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{075212663cf34a6eabbc03108ba4553e,

title = "Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes",

author = "JP Courreges and Tina Vilsb{\o}ll and M Zdravkovic and T Le-Thi and T Krarup and O Schmitz and R Verhoeven and I Buganova and Sten Madsbad",

year = "2008",

language = "English",

volume = "28",

pages = "1129--1131",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes

AU - Courreges, JP

AU - Vilsbøll, Tina

AU - Zdravkovic, M

AU - Le-Thi, T

AU - Krarup, T

AU - Schmitz, O

AU - Verhoeven, R

AU - Buganova, I

AU - Madsbad, Sten

PY - 2008

Y1 - 2008

M3 - Journal article

SN - 0742-3071

VL - 28

SP - 1129

EP - 1131

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 9

ER -